🔗 Permalink

Inventor profile of:

Thomas E. TARARA

City:

Burlingame, California

Country:

United States

Published Applications:

Last publication date:

2022-09-22

Top Assignees for applications by Thomas E. TARARA

The entities that hold a legal rights for patent applications filed by inventor TARARA Thomas E.:

NOVARTIS AG 16 Basel, Switzerland
NEKTAR THERAPEUTICS 5 San Carlos, CA United States
NOVARTIS PHARMA AG 2 Basel, Switzerland
Respira Therapeutics, Inc. 1 Albuquerque, NM United States
NOVARTIS AG 1 East Hanover, NJ United States
Novartis Vaccines and Diagnostics, Inc. 1 Emeryville, CA United States

Recent patent applications by TARARA Thomas E.

Thomas E. TARARA from Burlingame, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-09-22

US20220296521A1

Human necessities

CARRIER-BASED FORMULATIONS AND RELATED METHODS

#2 | 2016-12-08

US20160354388A1

Human necessities

Respirable agglomerates of porous carrier particles and micronized drug

#3 | 2015-12-31

US20150374623A1

Human necessities

DEAMORPHIZATION OF SPRAY-DRIED FORMULATIONS VIA SPRAY-BLENDING

#4 | 2014-12-25

US20140377361A1

Human necessities

STABLE METAL ION-LIPID POWDERED PHARMACEUTICAL COMPOSITIONS FOR DRUG DELIVERY

#5 | 2014-12-11

US20140363506A1

Human necessities

FORMULATION FOR PULMONARY ADMINISTRATION OF ANTIFUNGAL AGENTS, AND ASSOCIATED METHODS OF MANUFACTURE AND USE

#6 | 2014-10-09

US20140302147A1

Human necessities

Respirable agglomerates of porous carrier particles and micronized drug

#7 | 2014-07-31

US20140212504A1

Human necessities

Phospholipid-based powders for drug delivery

#8 | 2014-07-24

US20140206638A1

Human necessities

Pulmonary delivery of aminoglycoside

#9 | 2013-12-05

US20130319411A1

Human necessities

Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases

#10 | 2013-04-18

US20130095153A1

Human necessities

Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery

#11 | 2012-06-14

US20120148641A1

Human necessities

Methods of treatment of endobronchial infections

#12 | 2011-04-28

US20110097412A1

Human necessities

METHODS OF TREATMENT OF ENDOBRONCHIAL INFECTIONS

#13 | 2011-04-07

US20110082076A1

Human necessities

Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use

#14 | 2011-01-18

US9568818

Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use

#15 | 2010-12-30

US20100329984A1

Human necessities

Respiratory dispersion for metered dose inhalers comprising perforated microstructures

#16 | 2010-10-28

US20100272823A1

Human necessities

Pulmonary delivery particles comprising an active agent

#17 | 2009-12-08

US10644265

Stabilized preparations for use in metered dose inhalers

#18 | 2009-02-19

US20090047358A1

Human necessities

Phospholipid-based powders for drug delivery

#19 | 2008-10-28

US9851226

Phospholipid-based powders for drug delivery

#20 | 2008-09-25

US20080233194A1

Human necessities

Dispersion for pulmonary delivery of a bioactive agent

#21 | 2008-09-04

US20080214481A1

Human necessities

Methods of Treatment of Endobronchial Infections

#22 | 2008-05-06

US10327510

Pulmonary delivery of aminoglycosides

#23 | 2008-03-13

US20080063606A1

Human necessities

Pulmonary delivery of aminoglycoside

#24 | 2006-07-20

US20060159625A1

Human necessities

Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use

#25 | 2006-02-02

US20060025355A1

Human necessities

Compositions comprising amphotericin B, methods, and systems

#26 | 2005-09-22

US20050207986A1

Human necessities

Stabilized preparations for use in nebulizers

InventorID:

196847 ⎘